A comparison of surgical intervention and stereotactic body radiation therapy for stage i lung cancer in high-risk patients: A decision analysis

Journal of Thoracic and Cardiovascular Surgery

Volumn 143, Issue 2, 2012, Pages 428-436

  Puri, Varun ^a   Crabtree, Traves D ^a   Kymes, Steven ^a   Gregory, Martin ^a   Bell, Jennifer ^a   Bradley, Jeffrey D ^a   Robinson, Clifford ^a   Patterson, G Alexander ^a   Kreisel, Daniel ^a   Krupnick, Alexander S ^a   Meyers, Bryan F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICARE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HEALTH CARE COSTS; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MARKOV CHAINS; MEDICARE; MIDDLE AGED; MISSOURI; MODELS, ECONOMIC; NEOPLASM STAGING; PATIENT SELECTION; PROPENSITY SCORE; PULMONARY SURGICAL PROCEDURES; QUALITY-ADJUSTED LIFE YEARS; RADIOSURGERY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84855848597     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.10.078     Document Type: Article

References (26)

1. B.D. Kozower, S. Sheng, and S.M. O'Brien STS database risk models: predictors of mortality and major morbidity for lung cancer resection Ann Thorac Surg 90 2010 875 881
2. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
3. F.J. Lagerwaard, C.J. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
4. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 suppl 2007 S94 S100
5. J.D. Bradley, I. El Naqa, and R.E. Drzymala Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant Int J Radiat Oncol Biol Phys 77 2010 1146 1150
6. T.D. Crabtree, C.E. Denlinger, and B.F. Meyers Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer J Thorac Cardiovasc Surg 140 2010 377 386
7. I.S. Grills, V.S. Mangona, and R. Welsh Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
8. M.C. Weinstein, and J.A. Skinner Comparative effectiveness and health care spending - implications for reform N Engl J Med 362 2010 460 465
9. T.B. Lanni Jr., I.S. Grills, L.L. Kestin, and J.M. Robertson Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer Am J Clin Oncol 34 2011 494 498
10. D.J. Sher, J.O. Wee, and R.S. Punglia Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 2011 [Epub ahead of print]
11. J.P. Grutters, M. Pijls-Johannesma, and D.D. Ruysscher The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research Cancer Treat Rev 36 2010 468 476
12. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-effectiveness in health and medicine 1st ed 1996 Oxford University Press New York
13. G.L. Colice, M.A. Morley, C. Asche, and H.G. Birnbaum Treatment costs of community-acquired pneumonia in an employed population Chest 125 2004 2140 2145 (Pubitemid 38788182)
14. P. Jacobs, T.J. Marrie, and P. Calder Private costs of patients hospitalized with community-acquired pneumonia Can Respir J 12 2005 205 208 (Pubitemid 41065371)
15. W.K. Evans, B.P. Will, J.M. Berthelot, and C.C. Earle Cost of combined modality interventions for stage III non-small-cell lung cancer J Clin Oncol 15 1997 3038 3048 (Pubitemid 27377495)
16. M.C. Weinstein Recent developments in decision-analytic modeling for economic evaluation Pharmacoeconomics 24 2006 1043 1053 (Pubitemid 44683362)
17. E. Fenwick, K. Claxton, and M. Sculpher Representing uncertainty: the role of cost-effectiveness acceptability curves Health Economics 10 2001 779 787 (Pubitemid 34041389)
18. M. Hsie, S. Morbidini-Gaffney, and L.J. Kohman Definitive treatment of poor-risk patients with stage I lung cancer: a single institution experience J Thorac Oncol 4 2009 69 73
19. A.E. Martin-Ucar, A. Nakas, J.E. Pilling, K.J. West, and D.A. Waller A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients Eur J Cardiothorac Surg 27 2005 675 679 (Pubitemid 40409746)
20. B. Mahesh, C. Forrester-Wood, K. Amer, and R. Ascione Value of wedge resection for lung cancer in poor cardiopulmonary status patients Asian Cardiovasc Thorac Ann 14 2006 123 127
21. J.C. Garzon, C.S. Ng, and A.D. Sihoe Video-assisted thoracic surgery pulmonary resection for lung cancer in patients with poor lung function Ann Thorac Surg 81 2006 1996 2003 (Pubitemid 43775580)
22. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J Thorac Oncol 2 2007 706 714 (Pubitemid 47357522)
23. K. McKeage, C.M. Perry, and S.J. Keam Darunavir: a review of its use in the management of HIV infection in adults Drugs 69 2009 477 503
24. M. Nuijten, D.L. Andress, S.E. Marx, and R. Sterz Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: a US perspective Curr Med Res Opin 25 2009 1221 1234
25. M. McGregor Cost-utility analysis: use QALYs only with great caution CMAJ 168 2003 433 434 (Pubitemid 36255729)
26. J.R. Olsen, C.G. Robinson, and I. El Naqa Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 e299 e303